Uroplasty, Inc. (NASDAQ:UPI)

CAPS Rating: 2 out of 5

A medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions.

Results 1 - 21 of 24
Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
24vette 26.67 5/25/2012 Outperform 5Y $4.01 +4.24% +0.02% +4.22 0 Comment
HDTVBG 70.26 5/25/2012 Outperform 3W $3.94 +6.09% -0.17% +6.26 0 Comment
DavidSobel < 20 5/21/2012 Outperform 5Y $3.28 +27.44% +0.19% +27.25 0 Comment
ahknaten 99.38 3/21/2012 Underperform 5Y $2.91 +43.64% -5.99% -49.63 0 Comment
amishaw 79.33 3/21/2012 Underperform 5Y $2.91 +43.64% -5.99% -49.63 0 Comment
pro64grammer < 20 3/19/2012 Outperform 5Y $2.83 +47.70% -6.24% +53.94 0 Comment
bigdaddyderek 97.33 9/17/2010 3/14/2012 Underperform 3Y $4.28 -2.34% +16.86% +19.20 0 Comment
volumewhiz 98.90 2/15/2012 Outperform 3M $3.21 +30.22% -1.85% +32.07 0 Comment
SmartAce 97.73 2/7/2012 Outperform 5Y $3.57 +17.09% -2.10% +19.19 0 Comment
shaderules 26.04 1/30/2012 Outperform 5Y $3.53 +18.41% +1.22% +17.20 0 Comment
patelk10 99.79 1/27/2012 Outperform 5Y $3.52 +18.75% +0.49% +18.26 0 Comment
TraderDonJuan 82.18 5/27/2011 Outperform 3M $7.82 -46.55% -0.95% -45.60 0 Comment
TuttiBene < 20 11/24/2010 Outperform 5Y $5.35 -21.87% +10.01% -31.88 0 Comment
hobbatha < 20 9/17/2010 Outperform 3Y $4.28 -2.34% +16.86% -19.20 0 Comment
roth450 97.24 9/17/2010 Outperform NS $4.28 -2.34% +16.86% -19.20 0 Comment
bos4co49 < 20 9/17/2010 Outperform 1Y $4.28 -2.34% +17.41% -19.75 1 Comment
DiscountFinder < 20 6/28/2010 Outperform 5Y $5.11 -18.20% +22.28% -40.48 0 Comment
monthhighvolume < 20 6/22/2010 Outperform 5Y $5.84 -28.42% +18.57% -47.00 0 Comment
thisyearswinners 63.45 6/22/2010 Outperform 5Y $5.84 -28.42% +18.57% -47.00 0 Comment
daylowvolume < 20 6/22/2010 Outperform 5Y $5.84 -28.42% +18.57% -47.00 0 Comment
institutionsup 46.88 6/22/2010 Outperform 5Y $5.84 -28.42% +18.57% -47.00 0 Comment
Results 1 - 21 of 24

Featured Broker Partners


Advertisement